Bolli GB, Dimitriadis GD, Pehling GB, et al. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus. N Engl J Med. 1984;310:1706–11. https://doi.org/10.1056/NEJM198406283102605.
Article CAS PubMed Google Scholar
Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2008;25:501–4. https://doi.org/10.1111/j.1464-5491.2008.02413.x.
Article CAS PubMed Google Scholar
Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17:697–703. https://doi.org/10.2337/diacare.17.7.697.
Article CAS PubMed Google Scholar
Lawton J, Rankin D, Elliott J, et al. Experiences, views, and support needs of family members of people with hypoglycemia unawareness: interview study. Diabetes Care. 2014;37:109–15. https://doi.org/10.2337/dc13-1154.
Jensen MV, Broadley M, Speight J, et al. The impact of hypoglycaemia on the quality of life of family members of adults with type 1 or type 2 diabetes: A qualitative systematic review. Diabet Med. 2021;38:e14666. https://doi.org/10.1111/dme.14666.
Pieri BA, Bergin-Cartwright GAI, Simpson A, et al. Symptoms of Anxiety and Depression Are Independently Associated With Impaired Awareness of Hypoglycemia in Type 1 Diabetes. Diabetes Care. 2022;45:2456–60. https://doi.org/10.2337/dc21-2482.
Article CAS PubMed Google Scholar
Ali N, El Hamdaoui S, Nefs G, et al. High diabetes-specific distress among adults with type 1 diabetes and impaired awareness of hypoglycaemia despite widespread use of sensor technology. Diabet Med. 2023;40:e15167. https://doi.org/10.1111/dme.15167.
Article CAS PubMed Google Scholar
Amiel SA, Potts L, Goldsmith K, et al. A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc). Nat Commun. 2022;13:2229. https://doi.org/10.1038/s41467-022-29488-x.
Article CAS PubMed PubMed Central Google Scholar
Little S, Chadwick T, Choudhary P, et al. Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial). BMC Endocr Disord. 2012;12:33. https://doi.org/10.1186/1472-6823-12-33.
Article PubMed PubMed Central Google Scholar
Pratley RE, Kanapka LG, Rickels MR, et al. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020;323:2397–406. https://doi.org/10.1001/jama.2020.6928.
Article CAS PubMed PubMed Central Google Scholar
Choudhary P, Ramasamy S, Green L, et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care. 2013;36:4160–2. https://doi.org/10.2337/dc13-0939.
Article CAS PubMed PubMed Central Google Scholar
Reddy M, Jugnee N, El Laboudi A, et al. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia. Diabet Med. 2018;35:483–90. https://doi.org/10.1111/dme.13561.
Article CAS PubMed Google Scholar
van Beers CAJ, DeVries JH, Kleijer SJ, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 2016;4:893–902. https://doi.org/10.1016/S2213-8587(16)30193-0.
Beato-Víbora P, Yeoh E, Rogers H, et al. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2015;32:1453–9. https://doi.org/10.1111/dme.12869.
Article CAS PubMed Google Scholar
Ly TT, Nicholas JA, Retterath A, et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA. 2013;310:1240–7. https://doi.org/10.1001/jama.2013.277818.
Article CAS PubMed Google Scholar
Takagi S, Miura J, Shimura K, et al. A sensor augmented pump may improve awareness of hypoglycemia and quality of life in Japanese patients with type 1 diabetes mellitus. Diabetol Int. 2022;13:280–7. https://doi.org/10.1007/s13340-021-00538-x.
Kendall DM, Rooney DP, Smets YF, et al. Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy. Diabetes. 1997;46:249–57. https://doi.org/10.2337/diab.46.2.249.
Article CAS PubMed Google Scholar
Rickels MR. Recovery of endocrine function after islet and pancreas transplantation. Curr Diab Rep. 2012;12:587–96. https://doi.org/10.1007/s11892-012-0294-3.
Article PubMed PubMed Central Google Scholar
Hering BJ, Clarke WR, Bridges ND, et al. Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia. Diabetes Care. 2016;39:1230–40. https://doi.org/10.2337/dc15-1988.
Article CAS PubMed PubMed Central Google Scholar
Kamel JT, Goodman DJ, Howe K, et al. Assessment of the relationship between hypoglycaemia awareness and autonomic function following islet cell/pancreas transplantation. Diabetes Metab Res Rev. 2015;31:646–50. https://doi.org/10.1002/dmrr.2652.
Crabtree TSJ, Griffin TP, Yap YW, et al. Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study. Diabetes Care. 2023;46:1831–8. https://doi.org/10.2337/dc23-0635.
Article PubMed PubMed Central Google Scholar
Peacock S, Frizelle I, Hussain S. A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes Ther Res Treat Educ diabetes Relat Disord. 2023;14:839–55. https://doi.org/10.1007/s13300-023-01394-5.
Lunati ME, Morpurgo PS, Rossi A, et al. Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study. Front Endocrinol (Lausanne). 2022;13:816599. https://doi.org/10.3389/fendo.2022.816599.
McAuley SA, Trawley S, Vogrin S, et al. Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial. Diabetes Care. 2022;45:381–90. https://doi.org/10.2337/dc21-1667.
Article CAS PubMed Google Scholar
Veneman T, Mitrakou A, Mokan M, et al. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes. 1993;42:1233–7. https://doi.org/10.2337/diab.42.9.1233.
Article CAS PubMed Google Scholar
Handa T, Nakamura A, Miya A, et al. The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study. Diabetol Metab Syndr. 2021;13:37. https://doi.org/10.1186/s13098-021-00656-1.
Article CAS PubMed PubMed Central Google Scholar
Martín-Timón I, Del Cañizo-Gómez FJ. Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes. 2015;6:912–26. https://doi.org/10.4239/wjd.v6.i7.912.
Article PubMed PubMed Central Google Scholar
Nattero-Chávez L, Lecumberri Pascual E, De La Calle E, et al. Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms. Diabetes Res Clin Pract. 2023;199:110627. https://doi.org/10.1016/j.diabres.2023.110627.
留言 (0)